Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Comparative Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1501934

Extraordinary diversity of the CD28/CTLA4 family across jawed vertebrates

Provisionally accepted
  • 1 Warmwater Aquaculture Research Unit, Agricultural Research Service (USDA), Stoneville, Mississippi, United States
  • 2 Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, Scotland, United Kingdom
  • 3 University of Mississippi Medical Center, Jackson, Mississippi, United States
  • 4 School of Medicine, Emory University, Atlanta, Georgia, United States
  • 5 School of Medicine, University of Maryland, Baltimore, Maryland, United States
  • 6 INRAE Centre Jouy-en-Josas, Jouy-en-Josas, Île-de-France, France

The final, formatted version of the article will be published soon.

    Members of the CD28 family are critical for the control of immune cell activation. While CD28 and CTLA4 were previously identified in teleost fish, most members of the CD28 family have been described only in tetrapods. Using a comparative genomics approach, we found (co)orthologs of all members of the CD28 family both in Chondrichthyes and basal Osteichthyes groups, but not in Agnathans. Four additional members of the family were identified, which were present in both Chondrichthyes and Osteichthyes, some even in the tetrapod lineage but all of them absent in human. Herein, we extend the composition of the jawed vertebrate CD28 family to nine members: CD28, CTLA4, ICOS, CD28H, CD28HL1, CD28HL2, CD28HL3, CD28X and PD-1. Each of these genes had a single extracellular IgSF V domain, and conserved motifs in the V and the cytoplasmic domain. While a genomic cluster of three consecutive genes like CD28/CTLA4/ICOS was conserved across jawed vertebrates except in teleosts, the other members of the CD28 family were located on multiple chromosomes. Our findings show that these co-stimulatory/co-inhibitory receptors likely arose in early jawed vertebrates, and diversified when the Ig/ TCR/MHC-based adaptive immunity emerged, heralding the advent of complex regulatory networks controlling lymphocyte activation.

    Keywords: CD28, CTLA4, PD1, CD28H, ICOS

    Received: 25 Sep 2024; Accepted: 28 Oct 2024.

    Copyright: © 2024 Quiniou, Clark, Bengten, Rast, Ota, Flajnik and Boudinot. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Pierre Boudinot, INRAE Centre Jouy-en-Josas, Jouy-en-Josas, 78352, Île-de-France, France

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.